Tempest Therapeutics Filing Becomes Effective

Ticker: TPST · Form: EFFECT · Filed: Apr 6, 2026 · CIK: 0001544227

Tempest Therapeutics, Inc. EFFECT Filing Summary
FieldDetail
CompanyTempest Therapeutics, Inc. (TPST)
Form TypeEFFECT
Filed DateApr 6, 2026
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: filing-effectiveness, sec-filing, procedural

TL;DR

Tempest Therapeutics filing is now effective as of 4/3/2026. Go time.

AI Summary

Tempest Therapeutics, Inc. filed an EFFECT form with the SEC on April 6, 2026, indicating the effectiveness of a filing related to their securities. The effectiveness date is noted as April 3, 2026. The company's principal executive offices are located at 2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94005.

Why It Matters

This filing signifies that a previous registration statement or filing with the SEC has been approved and is now in effect, allowing for certain corporate actions or offerings to proceed.

Risk Assessment

Risk Level: low — An EFFECT filing itself is a procedural notification and does not inherently carry significant financial risk.

Key Numbers

  • 0001544227 — CIK (Tempest Therapeutics' unique identifier with the SEC.)
  • 333-294740 — File Number (The specific SEC file number associated with this filing.)

Key Players & Entities

  • Tempest Therapeutics, Inc. (company) — Filer
  • 2000 Sierra Point Parkway Suite 400 Brisbane CA 94005 (location) — Mailing and Business Address
  • 415-798-8589 (phone_number) — Contact Number
  • 0001544227 (cik) — Company Identification Number
  • 333-294740 (file_number) — SEC File Number
  • 2026-04-06 (date) — Acceptance Date
  • 2026-04-03 (date) — Effectiveness Date

FAQ

What type of filing is an 'EFFECT' form?

An 'EFFECT' form is a Notice of Effectiveness, indicating that a previously filed registration statement or other document with the SEC has been declared effective.

When was this filing accepted by the SEC?

This filing was accepted by the SEC on April 6, 2026.

What is the effectiveness date mentioned in the filing?

The effectiveness date mentioned is April 3, 2026.

Where are Tempest Therapeutics, Inc.'s principal offices located?

Tempest Therapeutics, Inc.'s principal offices are located at 2000 Sierra Point Parkway, Suite 400, Brisbane, CA 94005.

What is the SIC code for Tempest Therapeutics, Inc.?

The SIC code for Tempest Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 33 words · 1 min read · ~1 pages · Grade level 9.8 · Accepted 2026-04-06 00:15:20

Filing Documents

From the Filing

Notice of Effectiveness UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Notice of Effectiveness Effectiveness Date: April 3, 2026 4:00 P.M. Form: S-3 CIK: Company Name: Tempest Therapeutics, Inc. File Number: 333-294740

View Full Filing

View this EFFECT filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.